Combined treatment with lithium and nimodipine in a bipolar I manic syndrome

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 3, 1996, Pages 419-426

  Grunze, Heinz ^a,b,c   Walden, Jörg ^a   Wolf, Rainer ^a   Berger, Mathias ^a  

^a Psychiat Univ Klin Freiburg FRG   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bipolar disorder; Calcium antagonism; Lithium; Mania; Nimodipine

Indexed keywords

CALCIUM ANTAGONIST; LITHIUM; NIMODIPINE;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG COMBINATION; FEMALE; HUMAN; MANIA;

EID: 0029948678     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00006-1     Document Type: Article

References (48)

1. AMERICAN PSYCHIATRIC ASSOCIATION (1994): Diagnostic and Statistical Manual of Mental Disorders. Fourth Editìon, American Psychiatric Association, Washington, DC
2. BAASTRUP, P., HOLLANGEL, P., SORENSEN, R. and SCHOU, M. (1976): Adverse reactions in the treatment with lithium carbonate and haloperidol. JAMA 236: 2645-2646
3. BECH, P., RAFAELSEN, O.J., KRAMP, P. and BOLWIG, T.G. (1978): The mania rating scale: scale construction and inter-observer agreement Neuropharmacology 17, 430-431
4. BRUNET, G., CERLICH , B., ROBERT, S., DUMAS, S., SOUETRE, E. and DARCOURT, G. (1990): Open trial of a calcium antagonist, nimodipine, in acute mania. Clinical Neuropharmacology 13: 224-228
5. 2+ response in neutrophils of manic depressive patients: Effect of lithium therapy. Neuropsychobiology 27: 180-183
6. CHAUNDRY, R. and WATERS ,B. (1983): Lithium and carbamazepine interaction: possible neurotoxicity. J. Clin Psychiatry 44: 30-31
7. CHOI, J.J., HUANG, G.J., SHAFIK, E., WU, W. and McARDLE, J.J. (1992): Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins. J. Pharmacol.Exp.Ther. 263: 49-53
8. CHOU, J.C. (1991): Recent advances in the treatment of acute mania. J Clin. Psychopharmacol. 11: 3-21
9. COHEN, W. and COHEN, N. (1974).: Lithium carbonate, haloperidol, and irreversible brain damage. JAMA 230: 1283-1286
10. DUBOVSKY, S.L., FRANKS, R.D. and ALLEN, S. (1987).: Verapamil: a new antimanic drug with potential interactions with lithium. J.Clin.Psychiatry 48: 371-372
11. DUBOVSKY, S.L., CHRISTIANO, J., DANIELL, L.C. , FRANKS, R.D., MURPHY, J., ADLER, L., BAKER, N. and HARRIS, R.A. (1989):Increased intracellular calcium concentration in patients with bipolar affective disorders. Arch. Gen. Psychiatry 46: 632-638
12. DUBOVSKY, S.L., MURPHY, J., CHRISTIANO, J. and LEE, C. (1992): The calcium second messenger system in bipolar disorders: Data supporting new research directions. J. Neuropsychiatry Clin. Neurosci. 4: 3-14
13. DUBOVSKY, S.L. (1993): Calcium antagonists in manic depressive illness. Neuropsychobiology 22: 184-192
14. DUBOVSKY, S.L., THOMAS, M., HIJAZI, A. and MURPHY, J. (1994).: Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 243: 229-234
15. 2-receptor stimulation in platelets of depressed patients. Biol. Psychiat. 34; 565-568
16. EL-MALLAKH, R.S. (1983): The Na,K-ATPase hypothesis for manic-depression.. II.The mechanism of action of lithium. Med.Hypotheses 12: 269-282
17. FRITZE, J., BERNHARDT, T. and WALDEN, J. (1995): Clinical findings with nimodipine in dementia. J. Neural. Transm. (in press)
18. GLEN, A.I. (1985): Lithium prophylaxis of recurrent affective disorders. J.Affect.Disord. 8: 259-265
19. GREENWOOD, A.F. and JOPE, R.S. (1994).: Brain G-protein proteolysis by calpain: enhancement by lithium. Brain Res. 636: 320-326
20. HAMILTON, M. (1974): Hamilton Depression Scale. In: ECDEU Assessment Manual for Psychopharmacology, Rev. Ed., W. Guy and R.R. Bonato (Eds.), pp. 179-192, Rockville, MD
21. HOFFMEISTER, F., BENZ, U., HEISE, H., KRAUSE, P. and NEUSER, V. (1982): Behavioral effects of nimodipine in animals. Arzneimittel-Forschung 32: 347-360
22. KEITNER, G. and RAHMAN, S. (1984): Reversible neurotoxicity with combined lithium-haloperidol administration. J.Clin Psychopharmacol. 4: 104-105
23. KNORRING, L., SMIGAN, L., PERRIS, C. and ORELAND, L. (1982): Lithium and neuroleptic drugs in combination: Effects on Lithium RBC/Plasma ratio. Int Pharmacopsychiat. 17: 287-292
24. LANGLEY, M.S. and SORKIN, E.M. (1989): Nimodipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669-699
25. LENOX, R.H. and WATSON, D.G. (1994): Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clin Chem 40: 309-314
26. MAJ, M., PIROZZI, R. and STARACE, F. (1989a): Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J. of affective disorders 19: 237-241
27. MAJ, M., PIROZZI, R. and KEMALI, D. (1989b): Long-term outcome in patients originally classified as complete responders. Psychopharmacology 98: 535-538
28. MANNA, V. (1991): Disurbi affecttivi bipolari e ruolo del calcio intraneuronale: Effetti terapeutici del trattamento con sali di litio e/o calcio antagonista in pazienti con rapida inversione di polarita. Minerva Medica 82: 757-763
29. MILLER, F. and MENNINGER, J. (1987): Lithium-neuroleptic neurotoxicity is dose dependent. J.Clin. Psychopharmacol. 7: 89-91
30. OGATA, N., YOSHII, M. and NARAHASHI, T. (1989): Psychotropic drugs block voltage gated ion channels in neuroblastoma cells. Brain Res. 476: 140-144
31. OVERALL, J.E. and GORHAM, D.R. (1962): The Brief Psychiatric Rating Scale. Psychol.Rep.10, 799-812
32. PANDEY, G., GOEL, I. and DAVIS, J. (1979): Effect of neuroleptic drugs on lithium uptake by the human erythrocyte. Clin.pharmacol.Ther.26: 96-102
33. PANI, L., KUZMIN, A., DIANA, M., DE MONTIS, G., GESSA, G.L. and ROSSETTI, Z. (1990): Calcium receptor antagonists modify cocaine effects in the central nervous system differentially. Eur. J. Pharmacology 19:,217-221
34. PAZZAGLIA, P.J., POST, R.M., KETTER, T.A., GEORGE, M.S. and MARANGGELL, L.B. (1993): Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Research 49: 257-272
35. PEROUTKA, S.J (1983).: The pharmacology of calcium channel antagonists: A novel class of antimigraine agents ? Headache 23: 278-283
36. POST, R.M. (1990).: Lithium prophylaxis of recurrent affective disorders. J.Clin.Psychiatry 51 (suppl) : 9-19
37. POST, R., LEVERICH, G., PAZZAGLIA, P., MIKALAUSKAS, K. and DENICOFF, K. (1993): Lithium tolerance and discontinuation as pathways of refractoriness. In: Lithium in Medicine and Biology, N. Birch., C. Padgham, M. Hughes (Eds.), pp. 71-84, Marius Press, Carnforth.
38. PRAKASH, R., KELWALA, S. and BAN, T. (1982): Neurotoxicity with combined administration of lithium and a neuroleptic. Compr.Psychiatry 23: 567-571
39. PRICE, W. and ZIMMER, B. (1985).: Lithium-carbamazepine neurotoxicity in the elderly. J. Am.Geriatr. Soc. 33: 876-877
40. SHUKLA, S., GODWIN, C., LONG, L. and MILLER, M. (1984): Lithium-carbamazepine neurotoxicity and risk factors. Am.J. Psychiatry 141: 1604-1606
41. SPRING, G. (1979).: Neurotoxicity with combined use of lithium and thioridazine. J. Clin. Psychiat. 40: 135-138
42. SPRING, G. and FRANKEL, M. (1981): New data on lithium and haloperidol incompatibility. Am. J. Psychiatr. 138: 818-821
43. TAN, C.H., JAVORS, M.A., SELESHI, E., LOWREMORE, P.A. and BOWDEN, C.L. (1990):Effects of lithium on platelet ionic intracellular calcium concentrations in patients with bipolar (manic-depressive) disorder and healthy controls. Life Sciences 46: 1175-1180
44. WALDEN, J., GRUNZE, H., BINGMANN, D., LIU, Z. AND DÜSING, R. (1992): Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: Studies in calcium dependent model epilepsies. Eur. Neuropsychopharmacol. 2: 455-462
45. WALDEN, J., GRUNZE, H., MAYER, A., DÜSING, R., SCHIRRMACHER, K., LIU, Z. and BINGMANN, D. (1993): Calcium antagonistic effects of carbamazepine in epilepsies and affective psychoses. Neuropsychobiol.27: 171-175
46. WOOD (1985).: The neurochemistry of mania. The effect of lithium on catecholamines, indolamines and calcium mobilization. J. Affect.Disord. 8: 215-223
47. WORLD HEALTH ORGANIZATION (1992):The ICD-10 Classification of Mental and behavioral Diseases. World Health Organization, Geneva
48. von ZERSSEN, D.: Clinical self-rating scales of the Munich psychiatric information system (PSYCHIS München). In: Assessment of Depression, N. Sartorius and T.A. Ban (Eds.), pp.270-303, Springer, Berlin